Cationic Poly(Amino Acid) Vaccine Adjuvant for Promoting Both Cell-Mediated and Humoral Immunity Against Influenza Virus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Jong-Woo | - |
dc.contributor.author | Na, Woonsung | - |
dc.contributor.author | Kim, Hyun-Ouk | - |
dc.contributor.author | Yeom, Minjoo | - |
dc.contributor.author | Park, Geunseon | - |
dc.contributor.author | Kang, Aram | - |
dc.contributor.author | Chun, Haejin | - |
dc.contributor.author | Park, Chaewon | - |
dc.contributor.author | Oh, Seungseok | - |
dc.contributor.author | Van Phan Le | - |
dc.contributor.author | Jeong, Hyoung Hwa | - |
dc.contributor.author | Song, Daesub | - |
dc.contributor.author | Haam, Seungjoo | - |
dc.date.accessioned | 2021-09-01T21:55:50Z | - |
dc.date.available | 2021-09-01T21:55:50Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 2192-2640 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/68458 | - |
dc.description.abstract | Powerful adjuvants to augment vaccine efficacy with a less immunogenic vaccine system are in great demand. In this study, a novel squalene-based cationic poly(amino acid) adjuvant (CASq) that elicits both cellular (Th1) and humoral (Th2) immune responses is developed. CASq is demonstrated to promote cellular uptake of viral antigen and stimulate macrophages, leading to active production of interleukin-12. Furthermore, co-administration of inactivated pdm H1N1 vaccine with CASq significantly increases the generation of antigen-specific antibodies and T cell immune responses in mice, as well as resulting in complete prevention of disease symptoms and protection against lethal infection. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | DELIVERY | - |
dc.subject | NANOPARTICLES | - |
dc.subject | INDUCTION | - |
dc.subject | RESPONSES | - |
dc.subject | SQUALENE | - |
dc.title | Cationic Poly(Amino Acid) Vaccine Adjuvant for Promoting Both Cell-Mediated and Humoral Immunity Against Influenza Virus | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Na, Woonsung | - |
dc.contributor.affiliatedAuthor | Kim, Hyun-Ouk | - |
dc.contributor.affiliatedAuthor | Song, Daesub | - |
dc.identifier.doi | 10.1002/adhm.201800953 | - |
dc.identifier.scopusid | 2-s2.0-85058442959 | - |
dc.identifier.wosid | 000456802300012 | - |
dc.identifier.bibliographicCitation | ADVANCED HEALTHCARE MATERIALS, v.8, no.2 | - |
dc.relation.isPartOf | ADVANCED HEALTHCARE MATERIALS | - |
dc.citation.title | ADVANCED HEALTHCARE MATERIALS | - |
dc.citation.volume | 8 | - |
dc.citation.number | 2 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | INDUCTION | - |
dc.subject.keywordPlus | RESPONSES | - |
dc.subject.keywordPlus | SQUALENE | - |
dc.subject.keywordAuthor | adjuvants | - |
dc.subject.keywordAuthor | poly(amino acid) | - |
dc.subject.keywordAuthor | poly-l-lysine | - |
dc.subject.keywordAuthor | squalene | - |
dc.subject.keywordAuthor | vaccines | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.